HNCKF Stock UPDATES Hard Creek Nickel Corp (HNCKF) 0.0398 09/10/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Hard Creek Nickel Corp (HNCKF) 0.0398 $HNCKF

Hard Creek Nickel Provides Update on TSX Review
Marketwire - Fri Sep 05, 8:44AM CDT
Further to Hard Creek Nickel Corp. (TSX: HNC) press release dated May 5, 2014 the company intends to de-list its common shares from the TSX and has applied to list on the TSXV. The company had received notice from the Toronto Stock Exchange (the "TSX" stating that the TSX was reviewing the eligibility of the Company for continued listing of its securities on the TSX. Specifically, the TSX was evaluating the Company with respect to the following requirement: a minimum expenditure of $350,000 per year on exploration and or development work.

Hard Creek Nickel Corp. Releases Second Quarter Financial Statements and Management Discussion and Analysis
Marketwire - Fri Aug 08, 5:11AM CDT
Brian Fiddler, Chief Financial Officer of Hard Creek Nickel Corp. (TSX: HNC) is pleased to release its second quarter financial results for the period ending June 30, 2014. General and administrative expenses for the six months ended June 30, 2014 were $27,112 compared to $131,436 for the three months ended June 30, 2013.

Hard Creek Nickel Corporation Report of Voting Results
Marketwire - Mon Jun 23, 2:24PM CDT
Pursuant to Section 11.3 of National Instrument 51-102, the following matters were put to vote at the Annual General Special Meeting of Hard Creek Nickel Corporation (the "Issuer" (TSX: HNC) held on June 23, 2014:

Hard Creek Settles With CRA
Marketwire - Wed Jun 18, 8:35AM CDT
Mark Jarvis, President of Hard Creek Nickel Corp. (TSX: HNC), announced today that the Company has received $265,345.46 from the Canada Revenue Agency (CRA) in settlement of a long running dispute regarding B.C. Mineral Exploration Tax Credits (BCMETC) from Canadian Exploration Expenses (CEE) spent during the years 2003 - 2008.

Terra Nova Energy Appoints Mark Jarvis & Lyle Davis as Directors
ACCESSWIRE - Tue Feb 18, 4:06AM CST
VANCOUVER - /ACCESSWIRE/ - Feb. 18, 2014 - Terra Nova Energy Inc. ("Terra Nova" or the "Company" (TSXV: TGC) is pleased to announce the appointment of Mark Jarvis & Lyle Davis to its board of directors.

Hard Creek Nickel Adopts Advance Notice Policy for Director Nominations
Marketwire - Mon May 06, 10:03AM CDT
Mark Jarvis, President of Hard Creek Nickel Corp. (the "Company" (TSX: HNC) announced the approval today by its board of directors of an advance notice policy (the "Policy" , which Policy, among other things, includes a provision that requires advance notice to the Company in circumstances where nominations of persons for election to the board of directors are made by shareholders of the Company other than pursuant to (i) a "proposal" made in accordance with part 5, Division 7 of the Business Corporations Act (British Columbia) (the "Act" ; or (ii) a requisition of the shareholders made in accordance with Section 167 of the Act.

Hard Creek Nickel Corporation: Stock Options Granted
Marketwire - Fri Jan 04, 2:43PM CST
Hard Creek Nickel Corporation (the "Company" (TSX: HNC) today announces that pursuant to its Stock Option Plan, approved by the Toronto Stock Exchange, the Company will be granting 2,650,000 stock options to certain Consultants, Directors, Officers and Employees, exercisable at $0.10 per share, expiring January 4, 2018.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 399

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 448

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 72

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 0

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Ascletis' Preclinical Successes: Future of Obesity Treatment

Updated Category News Views 14

Pharma Giants Eyeing a New Potential Well, it seems the world of pharma is buzzing with Ascletis’ latest developments in the obesity treatment arena. They’ve just showcased some intriguing preclinical data at ObesityWeek® 2026. The standout? A cocktail of advancements that might just put a dent in the obesity epidemic if further studies pan out. ASC30_48: A Daily...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 412

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 89

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 284

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 115

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading

Top 5 Most Recently Viewed Articles

O-I Glass Announces Participation in Citi’s 2025 Conference

Updated Category News Views 208

O-I Glass Participation in the 2025 Basic Materials Conference PERRYSBURG, Ohio — O-I Glass, Inc., known for its commitment to creating exceptional glass products, is set to participate in the upcoming Citi’s 2025 Basic Materials Conference. This significant event will take place on a Wednesday in December, and features notable presentations from O-I's leadership....

Continue Reading
Osmium Partners Proposes Strategic Plan for Articore Growth

Updated Category News Views 104

Osmium Partners Proposes a Four-Step Plan for Articore Osmium Partners has recently made headlines with their proposal for Articore, aiming to elevate shareholder value through a methodical four-step approach. This initiative is driven by Osmium's belief that Articore's current management strategy lacks direction and has resulted in missed opportunities for growth and...

Continue Reading
Amplify Energy Set to Shine at EnerCom Denver Conference 2025

Updated Category News Views 135

Amplify Energy’s Participation in EnerCom Denver Conference Amplify Energy Corp. is gearing up to participate in the renowned annual EnerCom Denver Conference in 2025. This event, known for bringing together leading experts and investors in the energy sector, offers Amplify a prime platform to showcase its strategic initiatives and growth potential. Focus on Investor...

Continue Reading
Safe Life Expands CPR Training and AED Services through Acquisition

Updated Category News Views 197

Safe Life Strengthens National Coverage for Life-Saving Training Safe Life has made a significant move by acquiring HeartCert, a company known for its specialization in automated external defibrillators (AEDs) and CPR training. This acquisition allows Safe Life to broaden its reach into the Midwest, enhancing its commitment to providing life-saving training and equipment...

Continue Reading
Express Scripts Challenges FTC's Drug Pricing Conclusions

Updated Category News Views 106

Express Scripts Files Lawsuit Against the FTC Express Scripts, a major player in the pharmacy benefit manager sector, has recently taken legal action against the U.S. Federal Trade Commission (FTC). This lawsuit stems from a report that criticizes the role of pharmacy benefit managers in the pricing of medications. Express Scripts contends that the report's conclusions...

Continue Reading